<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">Etoposide-based treatment is the standard of care for sHLH following the Consensus Statements by the HLH Steering Committee of the Histiocyte Society. The treatment aims at dampening the cytokine storm and is based on etoposide and dexamethasone with intrathecal methotrexate in case of central nervous system involvement 
 <xref rid="b0070" ref-type="bibr">[14]</xref>, 
 <xref rid="b0075" ref-type="bibr">[15]</xref>.
</p>
